ScholarWorks@Gachon: Yadav, Dharmendra Kumar

Detailed Information

Yadav, Dharmendra Kumar (Dharmendra Kumar Yadav)

Pharmacy (Department of Biologics)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

SARSCoV2:9||drug discovery:6||Molecular dynamics simulation:6||virtual screening:5||anticancer:5||molecular docking:5||molecular dynamics:5||Virtual screening:4||Drug discovery:4||Natural products:4||variant:4||antioxidant:3||Artemisinin:3||Molecular dynamics:3||breast cancer:3||Transcription factor:3||molecular dynamics simulation:3||docking:3||DPPH:3||antioxidant activity:3||neutralization:3||Cancer therapy:3||efficacy:2||Inhibitors:2||ADMET:2||Neurodegenerative diseases:2||Spectroscopy:2||reactive oxygen species:2||Breast cancer:2||s disease:2||Alzheimer's disease:2||RAGE:2||antibody:2||COVID19:2||structureactivity relationship:2||Drug repurposing:2||ROS generation:2||Anticancer:2||infectivity:2||Apoptosis:2||treatment:2||apoptosis:2||vaccine:2||betaglucan:2||FRAP:2||MD simulation:2||molecular dynamics simulations:2||Targeted therapy:2||Aldose reductase:2||cancer:2||natural compounds:2||Human transferrin:2||Therapeutic target:2||Fluorescence spectroscopy:2||CRISPR/Cas9:2||cervical cancer:2||Antioxidant:2||oxidative stress:2||Clinical trials:2||Triplenegative breast cancer:2||Tumorigenesis:2||Phytochemicals:2||Signaling pathway:2||Signaling pathways:2||phytoconstituents:2||Vaccine development:2||Phytoconstituents:2||Diabetes mellitus:1||Diabetic nephropathy:1||Diabetic neuropathy:1||Diagnostic:1||Diagnostics:1||Differential gene expression:1||Docking:1||Double C[sbnd]H bond activation:1||Drug–protein interactions:1||Drug resistance:1||Drug resistance reversal:1||Drug targets:1||Drugresistance:1||Dynamical crosscorrelation matrices:1||EGFR:1||EGFR pathway:1||Efflux pump inhibition:1||Endophyte:1||Enteric nervous system:1||Enzyme inhibition:1||Epigallocatechin gallate:1||Epigenetic regulations:1||Epithelial sodium channel:1||Escherichia coli (E. coli):1||Essential oil:1||Ex vivo permeation:1||Extracellular vesicle:1||FDA—Food and drug administration:1||Flavonoids:1||GV1001:1||Gastrointestinal dysfunction:1||Gaussian Based 3DQSAR:1||Gene editing:1||Gene network:1||Glabrene:1||Glioma:1||Glycosides:1||GnRH:1||Green tea extracts:1||Gutbrain axis:1||HER2positive:1||Head and neck squamous cell carcinoma:1||Helicases:1||Hostbased therapy:1||Human serum albumin:1||Huperzine A:1||Hyperglycemia:1||Immune response:1||Inflammatory diseases:1||Insilco approach:1||Intrinsically disordered proteins:1||Iron:1||Iron homeostasis:1||Iron neurochemistry:1||Isoglycyrol:1||Isothermal titration calorimetry:1||JAK2:1||Kinase inhibitors:1||Kinases:1||Lipid metabolism:1||Lupinisoflavone C:1||MD simulations:1||MDR:1||MIC:1||MMGBSA:1||MMGBSA analysis:1||MMGBSA:1||Main protease (Mpro):1||Malaria:1||Metastasis:1||Microbial dysbiosis:1||Microbiome:1||Microtubule dynamics:1||Microwave:1||MicrowaveAssisted Organic Synthesis (MAOS):1||Minimum inhibitory concentration:1||Molecular docking:1||Molecular dynamic simulation:1||Molecular pathogenesis:1||Multidrug resistant strains:1||Multiple sequence alignment:1||Mutations:1||NTAP viral inactivation:1||NVPBSK805:1||Natural compounds:1||Network analysis:1||Neurodegeneration:1||Neurodegenerative diseases:1||Neurodegenerative disease:1||Neurodegenerative disorders:1||Neurogenerative disease:1||Neuroinflammation:1||Neuronal development:1||Neuropsychiatric Disorders:1||Neuropsychological:1||Niaziridin:1||Niazirin:1||Nonthermal biocompatible plasma (NBP):1||Pglycoprotein:1||Pgp:1||PARP (poly(ADPribose) polymerase):1||PARP12:1||PGPR:1||PRED:1||Parasite proteases:1||Parkinson&apos:1||Parkinson’s disease:1||Pathophysiology:1||Phosphatidylinositol 4,5bisphosphate 3kinase catalytic subunit alpha:1||Phospholipids:1||Plasmodium falciparum drug development:1||Principal components analysis:1||Prolyl hydroxylase:1||Protein kinase:1||Proteinprotein interaction:1||QSAR:1||RAGE inhibitor:1||RASRAFMEKERK pathway:1||RET = rearranged during transfection:1||RQSAR:1||Reactive nitrogen species (RNS):1||Reactive oxygen species (ROS):1||Renal fibrosis:1||Resveratrol:1||Ribosomal protein S6 kinase 1:1||Rosmarinic acid:1||SAR:1||SARSCOV2:1||SARSCoV2 cell entry inhibitors:1||SARSCoV2 mutations:1||SARSCoV2 pathogenesis:1||Salmonella typhimurium (sepsis):1||Sertindole:1||Serum glucocorticoid kinase:1||Shikonin:1||Skin irritation:1||Small molecule inhibitors:1||Smart probes:1||Sonogashira coupling:1||Staphylococcus aureus (S. aureus):1||Structure interaction fingerprint analysis:1||StructureActivity Relationship:1||Structureactivity relationship:1||Structurebased drug design:1||Survival analysis:1||Sustainedrelease:1||Synthetic compounds:1||Synthetic ozonides:1||Synthetic route:1||TANKbinding kinase 1:1||TBHP:1||TNBC:1||TNFalpha:1||TRPV1 receptor:1||Targetpropelled therapy:1||Temoporfin:1||Therapeutic:1||Therapeutic applications:1||Therapeutic targeting:1||Thieno[3:1||Thymoquinone:1||Trioxane:1||Triple negative breast cancer:1||Unani transdermal patch:1||Ursolic acid:1||Ustukhuddu over bar s:1||Virusbased therapy:1||YES1 kinase:1||ZINCFDA:1||activin receptorlike kinase 1:1||alkaloids:1||allosteric site:1||antiinflammatory:1||antibacterial activity:1||antibacterial combinations:1||anticancer properties:1||anticancer therapy:1||antioxidants:1||antiplasmodial:1||antiplatelet:1||antiplatelet activity:1||arachidonic acid:1||artemisinin:1||artesunate:1||ascorbic acid:1||beverage:1||bioremediation:1||biosorption:1||cadmium:1||cancer therapy:1||cancer vaccine:1||capsaicin:1||capsaicinoids:1||cardiovascular disease:1||chanoclavine:1||clinical practice:1||coronavirus disease 2019:1||coronavirus disinfection:1||cytokines:1||cytotoxicity:1||dementia:1||diagnosis:1||drug design:1||drug repurposing:1||drug resistance reversal:1||drug treatment:1||efflux pump inhibitor:1||electric field:1||electroporation:1||end products:1||epidemiology:1||erucin:1||frankincense oil:1||free energy landscape:1||free energy profile:1||graphene oxidechitosan:1||hTERT:1||health benefits:1||heavy metals:1||hydroperoxide:1||immune response:1||in silico ADMET:1||in silico molecular docking:1||inflammatory diseases:1||insulin resistance:1||insulin signaling:1||intramolecular interactions:1||kinase inhibitors:1||lipid peroxidation:1||long noncoding RNA:1||mechanism of action:1||microRNAs:1||multidrugresistant Escherichia coli (MDREC):1||multidrugresistant bacteria:1||nanocomposite:1||nanoemulsion:1||nanoparticle:1||natural products:1||ncRNAs:1||neurodegeneration:1||neutralization therapy:1||nonthermal plasma:1||novel combinations:1||nuclear receptor:1||oral squamous cell carcinoma:1||paclitaxel:1||pathophysiology:1||personalized medicine:1||pharmacophore:1||pharmacophore model:1||pharmacophorebased filter:1||phylogenetic tree:1||phytostabilization:1||plasma medicine:1||platelet aggregation inhibitors:1||pneumonia:1||prolactin inducible protein:1||prolyl hydroxylase:1||prostate cancer:1||radicals:1||reactive oxygen and nitrogen species:1||refrigeration storage:1||severe acute respiratory syndrome coronavirus2:1||shelflife:1||signaling molecules:1||single amino acid substitutions:1||sitedirected mutagenesis:1||small proteins:1||stability:1||structureactivity relationships:1||synergism:1||targeted therapy:1||therapy:1||thermal processing:1||tomato:1||toxic elements:1||trioxane:1||type2 diabetes mellitus:1||tyrosine kinase inhibitors:1||vitamin D receptor:1||withanolides:1||α:1||αSynuclein:1||1,2,4Trioxolane:1||βDehydrocurvularin:1||1,2,4trioxanes:1||2c]pyran2ones:1||2oxobenzo[1,4]oxazine:1||2oxobenzo[1,4]oxazines:1||2oxobenzo[1,4]oxazines:1||2oxoquino[1,4]oxalines:1||3Phenyl1Hisochromen1one:1||4Trioxane:1||6endodig cyclization:1||ACE2 allelic variants:1||ADME:1||AKT1:1||AQP3 protein:1||Aducanumab:1||Alzheimer&apos:1||Alzheimer’s drug:1||Anticancer:1||Anticancer drug resistance:1||Anticancer therapy:1||Antiinflammatory:1||Antiinflammatory agents:1||Antimalaria:1||Antioxidant:1||Antibacterial combinations:1||Anticancer drug resistance:1||Antidiabetic properties:1||Antimalarial:1||Antimalarial peroxides:1||Antimicrobial.:1||Antiplatelet:1||Apolipoprotein E:1||Apollinine:1||AutoQSAR:1||B cell lymphoma 2:1||BHT:1||Bax/Bcl2:1||Benzo[1,4]oxazines:1||Benzopyran:1||Bioactive phenolic compounds:1||Biofilm synthesis:1||Biomarker:1||Brain:1||CEP33779:1||COVID19 therapeutics:1||COVID19:1||COX2:1||CRISPR:1||Cabinet sterilizer:1||Cancer:1||Cancer therapeutics:1||Cancers:1||Candidine:1||Capsicum annuum:1||Cas9:1||Casein kinase1 alpha:1||Chemotherapy:1||Chili:1||Clinical trial:1||Combination therapy:1||Computational approach:1||Computational drug discovery:1||Crossdehydrogenative coupling (CDC):1||Curcumin:1||Curtobacterium oceanosedimentum:1||Cyclinependent:1||DNA damage repair:1||

STATISTICS: Total View :4,136,912; Today View :4,470

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE